Ameriprise Financial Inc Haemonetics Corp Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 235,529 shares of HAE stock, worth $19.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,529

Previous 229,497 2.63%

Holding current value

$19.3 Million

Previous $19 Million 0.3%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $437,018 - $552,410	6,032 Added 2.63%	235,529 $18.9 Million
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $3.49 Million - $4.19 Million	-43,003 Reduced 15.78%	229,497 $19 Million
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $1.04 Million - $1.24 Million	-14,560 Reduced 5.07%	272,500 $23.3 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $8.04 Million - $9.24 Million	-99,746 Reduced 25.79%	287,060 $24.5 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $101,796 - $115,273	-1,233 Reduced 0.32%	386,806 $34.7 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $5.84 Million - $6.46 Million	-72,203 Reduced 15.69%	388,039 $33 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $1.05 Million - $1.3 Million	14,366 Added 3.22%	460,242 $38.1 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $540,729 - $630,717	-7,322 Reduced 1.62%	445,876 $35.1 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $3.49 Million - $4.34 Million	55,121 Added 13.85%	453,198 $33.6 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $11.1 Million - $14.8 Million	224,492 Added 129.33%	398,077 $25.9 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $4.47 Million - $6.45 Million	102,015 Added 142.54%	173,585 $11 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $119,118 - $179,314	-2,404 Reduced 3.25%	71,570 $3.8 Million
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $2.09 Million - $2.56 Million	-36,216 Reduced 32.87%	73,974 $5.22 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $33.4 Million - $76.5 Million	-645,234 Reduced 85.41%	110,190 $7.34 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $10.7 Million - $13.4 Million	96,006 Added 14.56%	755,424 $83.9 Million
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $15.4 Million - $20.8 Million	173,686 Added 35.76%	659,418 $78.3 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $4.9 Million - $6.06 Million	64,746 Added 15.38%	485,732 $42.4 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $2.66 Million - $3.72 Million	31,254 Added 8.02%	420,986 $37.7 Million
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $20.5 Million - $33.7 Million	276,340 Added 243.7%	389,732 $38.8 Million
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $1.55 Million - $1.75 Million	-13,519 Reduced 10.65%	113,392 $13 Million
Q3 2019 Nov 14, 2019	SELL	$117.16 - $138.52 $1.47 Million - $1.73 Million	-12,516 Reduced 8.98%	126,911 $16 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $18.9 Million - $27.9 Million	-231,732 Reduced 62.43%	139,427 $16.8 Million
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $5.35 Million - $6.56 Million	-64,252 Reduced 14.76%	371,159 $32.5 Million
Q4 2018 Feb 14, 2019	BUY	$90.66 - $116.63 $839,874 - $1.08 Million	9,264 Added 2.17%	435,411 $43.6 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $20.7 Million - $26.3 Million	-229,627 Reduced 35.02%	426,147 $48.8 Million
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $41.4 Million - $55.4 Million	-578,215 Reduced 46.86%	655,774 $58.8 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $41.2 Million - $50.5 Million	678,660 Added 122.21%	1,233,989 $90.3 Million
Q4 2017 Feb 12, 2018	SELL	$44.96 - $58.99 $1.05 Million - $1.38 Million	-23,388 Reduced 4.04%	555,329 $32.3 Million
Q3 2017 Nov 07, 2017	BUY	$40.38 - $44.87 $23.4 Million - $26 Million	578,717	578,717 $26 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Haemonetics Corp Transaction History